Turk Ilac ve SerumnayiIST:TRILC -2.48%61 OCF Yield % is 57.66 as of Jul. 03, 2026, which is 3332% above its 10-year median of 1.68. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Turk Ilac ve Serumnayi ranks better than 98.71% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Turk Ilac ve Serumnayi OCF Yield % Related Terms
Turk Ilac ve Serumnayi OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:TRILC vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Turk Ilac ve Serumnayi OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Turk Ilac ve Serumnayi's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Turk Ilac ve Serumnayi (IST:TRILC) has a OCF Yield % of 57.66 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Turk Ilac ve Serumnayi and its competitors. This is 3332% above median its historical median of 1.68. According to the industry distribution chart, Turk Ilac ve Serumnayi ranks #13 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is Turk Ilac ve Serumnayi's OCF Yield % too high?
Turk Ilac ve Serumnayi's current OCF Yield % of 57.66 is 3332% above median its 10-year median of 1.68. The Drug Manufacturers industry median OCF Yield % is 3.43. Turk Ilac ve Serumnayi's value of 57.66 is 1581% above this industry median. Based on the distribution chart, Turk Ilac ve Serumnayi ranks #13 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Turk Ilac ve Serumnayi ranks #13 out of 1007 companies for OCF Yield %. This places Turk Ilac ve Serumnayi in the top 1% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. Turk Ilac ve Serumnayi's value of 57.66 is 1581% above this benchmark. While the company's 10-year median is 1.68 vs. the industry median of 3.43, Turk Ilac ve Serumnayi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Turk Ilac ve Serumnayi's current OCF Yield % of 57.66 is 1581% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Turk Ilac ve Serumnayi and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Turk Ilac ve Serumnayi's current OCF Yield % is 57.66, which is 3332% above median its own 10-year median of 1.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current OCF Yield % is 57.66, which is 3332% above median its 10-year median of 1.68 and 1581% above the Drug Manufacturers industry median of 3.43. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current OCF Yield % is 57.66 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued.
The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60.
GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.
Key valuation signals for IST:TRILC:
OCF Yield %: 57.66 (3332% above median its 10-year median of 1.68)
GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
Industry Position: 1581% above the Drug Manufacturers median (#13 of 1007)
No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:TRILC has been successfully added to your 
